Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine - PubMed (original) (raw)
Affiliations
- PMID: 2496273
Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine
K Nicholls et al. Lab Invest. 1989 Apr.
Abstract
The effects of islet isografting and of aminoguanidine on the accumulation of advanced glycosylation end-products (AGE) in renal basement membranes were studied in Streptozotocin (STZ)-induced diabetes mellitus in female BALB/c mice. The characteristic autofluorescence of glycosylated collagen was used to quantitate AGE. We studied the effect of islet isografting using 3 groups of mice, sacrificed at age 13 to 15 months: group A, untreated diabetes (STZ 250 mg/kg intravenously at age 6 to 8 weeks); group B, untreated diabetes for 7 months, then successfully grafted with cultured islet cells; and group C, age-matched normal control animals. At sacrifice, AGE were measured in digests of renal basement membranes as collagen-linked fluorescence/unit of hydroxyproline. Group A animals had significantly greater renal basement membrane glycosylation than did the other 2 groups, (group A median 88.0 arbitrary units/mumol hydroxyproline, range 30.2 to 127.5; group B median 19.4, range 5.1 to 56.8; group C median 2.9 range 0-13.5; p = .001 A versus B). To study the effect of aminoguanidine, 4 groups of animals were used: group 1, untreated diabetics (STZ 250 mg/kg intravenously at age 6 to 8 weeks); group 2, diabetics treated with aminoguanidine 50 mg/kg intraperitoneally daily; group 3, age-matched control animals, and group 4, age-matched controls treated with aminoguanidine. At sacrifice after 7 months, AGE were measured in digests of renal basement membranes as collagen-linked fluorescence/unit of hydroxyproline. Aminoguanidine significantly attenuated the accumulation of AGE in diabetic mice (group 1 median 47.2 arbitrary units/mumol hydroxyproline, range 16.1 to 56.0; group 2 median 24.4, range 5.0 to 37.7; group 3 median 13.6, range 0 to 30.3; group 4 median 10.8, range 2.1 to 17.2; p less than 0.01, groups 1 versus 2). These results indicate that further basement membrane glycosylation is prevented by restoration of euglycemia by islet grafting after a significant duration of diabetes, and that aminoguanidine prevents AGE accumulation despite hyperglycemia.
Similar articles
- Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
Gardiner TA, Anderson HR, Stitt AW. Gardiner TA, et al. J Pathol. 2003 Oct;201(2):328-33. doi: 10.1002/path.1429. J Pathol. 2003. PMID: 14517851 - The protective effect of aminoguanidine on erectile function in diabetic rats is not related to the timing of treatment.
Usta MF, Bivalacqua TJ, Koksal IT, Toptas B, Surmen S, Hellstrom WJ. Usta MF, et al. BJU Int. 2004 Aug;94(3):429-32. doi: 10.1111/j.1464-410X.2004.04937.x. BJU Int. 2004. PMID: 15291881 - Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
Friedman EA. Friedman EA. Diabetes Care. 1999 Mar;22 Suppl 2:B65-71. Diabetes Care. 1999. PMID: 10097902 Review. - [Aminoguanidine].
Kawano M, Kawakami M. Kawano M, et al. Nihon Rinsho. 1997 Nov;55 Suppl:221-4. Nihon Rinsho. 1997. PMID: 9434471 Review. Japanese. No abstract available.
Cited by
- Proteomic Insight Reveals Elevated Levels of Albumin in Circulating Immune Complexes in Diabetic Plasma.
Bhat S, Jagadeeshaprasad MG, Patil YR, Shaikh ML, Regin BS, Mohan V, Giri AP, Balasubramanyam M, Boppana R, Kulkarni MJ. Bhat S, et al. Mol Cell Proteomics. 2016 Jun;15(6):2011-20. doi: 10.1074/mcp.M116.058008. Epub 2016 Apr 7. Mol Cell Proteomics. 2016. PMID: 27056913 Free PMC article. - Involvement of advanced glycation end products, oxidative stress and nuclear factor-kappaB in the development of diabetic keratopathy.
Kim J, Kim CS, Sohn E, Jeong IH, Kim H, Kim JS. Kim J, et al. Graefes Arch Clin Exp Ophthalmol. 2011 Apr;249(4):529-36. doi: 10.1007/s00417-010-1573-9. Epub 2010 Nov 23. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21104267 - The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity.
Takino J, Kobayashi Y, Takeuchi M. Takino J, et al. J Gastroenterol. 2010 Jun;45(6):646-55. doi: 10.1007/s00535-009-0193-9. Epub 2010 Jan 19. J Gastroenterol. 2010. PMID: 20084527 - Cells and tissue interactions with glycated collagen and their relevance to delayed diabetic wound healing.
Liao H, Zakhaleva J, Chen W. Liao H, et al. Biomaterials. 2009 Mar;30(9):1689-96. doi: 10.1016/j.biomaterials.2008.11.038. Epub 2009 Jan 20. Biomaterials. 2009. PMID: 19157537 Free PMC article. - [Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus].
Nawroth PP, Bierhaus A, Vogel GE, Hofmann MA, Zumbach M, Wahl P, Ziegler R. Nawroth PP, et al. Med Klin (Munich). 1999 Jan 15;94(1):29-38. doi: 10.1007/BF03044692. Med Klin (Munich). 1999. PMID: 10081287 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical